GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Tax Expense

Elixxer (Elixxer) Tax Expense : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer Tax Expense?

Elixxer's tax expense for the months ended in Sep. 2023 was $0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.


Elixxer Tax Expense Historical Data

The historical data trend for Elixxer's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Tax Expense Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Elixxer Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixxer  (OTCPK:ELIXF) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Elixxer Tax Expense Related Terms

Thank you for viewing the detailed overview of Elixxer's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (Elixxer) Business Description

Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (Elixxer) Headlines

From GuruFocus

Little Green Pharma Holding exceeds $15M in value for Elixxer

By Marketwired Marketwired 12-01-2020

Elixxer Ltd. Closes $4 Million Secured Loan

By Marketwired Marketwired 10-08-2020

Little Green Pharma achieves key milestone in commercial strategy

By Marketwired Marketwired 07-20-2020

Elixxer Ltd. Closes Private Placement

By Marketwired Marketwired 10-15-2020

Elixxer Ltd. Announces Revised Debt Settlement Transactions

By Marketwired Marketwired 03-02-2021

Little Green Pharma Continues Record Breaking Sales Growth

By Marketwired Marketwired 05-28-2020

Elixxer Ltd. Provides Update on Proposed Private Placement

By GlobeNewswire GlobeNewswire 10-08-2020